Download presentation
1
Andrology and IVF Laboratory Services
Charles L. Bormann, PhD IVF/Andrology Laboratory Supervisor 1
2
Laboratory Regulations
Mark P.D. Dow PhD, HCLD (Laboratory Director) Charles L. Bormann MS, PhD (Laboratory Supervisor) Lynn Boehnlein BS, MT,TS (Senior Embryologist) Elizabeth Schleinz BS, MT,TS (Senior Embryologist) Clinical Laboratory Improvement Amendments (CLIA) Food and Drug Administration (FDA) College of American Pathologists (CAP) Society for Assisted Reproductive Technology (SART)
3
Semen Analysis Abstain 2-3 days prior to analysis
Collect in an approved sterile cup or condom Do not use lubricants for collection Sample processed within 1 hour of collection
4
World Health Organization
Parameters Volume >2ml pH Sperm Concentration >20 million/ml Sperm Motility >50% Progression/Speed ≤3 Sperm Viability ≥50% Morphology (Krueger) ≥14% Round Cells ≤5/hpf DNA Fragmentation ≤30% Viscosity
5
Sperm Motility *Motility *Forward Progression *Velocity
6
Sperm Morphology
7
Sperm DNA Fragmentation
8
Sperm DNA Fragmentation
Density Gradient Density Gradient Spin Wash Swim-Up
9
Sperm Viability Tests Viability Stain Pentoxifylline
Hypo-Osmotic Swelling (HOS)
10
Donor Sperm Purpose: Offer a chance at pregnancy to those without a male partner, or if male partner’s sperm are absent, unable to fertilize, carry a genetic disease, etc
11
Donor Sperm Photos and personal information also available
12
Inter-Uterine Insemination (IUI)
Semen Wash DGS Remove seminal plasma Remove debris (WBC, dead sperm) Enrich highly motile sperm population Centrifuge, remove supernatant Centrifuge, remove top layers Wash Wash Count/Assess Reconstitute Load catheter
13
Intracytoplasmic Sperm Injection (ICSI)
14
Fertilization ~ 18h post insemination Female Pronucleus Male
2 1 1 3 1 2 4 6 5 3
15
Embryo Development
16
The in vitro environment was designed to mimic mother nature
In Vitro Culture The in vitro environment was designed to mimic mother nature
17
Embryo Development Days 1-3 Days 4-6 2-Cell 4-Cell 8-Cell Morula
Blastocyst Hatching Blastocyst Days 4-6
18
Day 3 vs. Day 5 Embryo Transfer
8AA 2CB 3BB 4AB 4AA
19
Preimplantation Genetic Diagnosis
Recurrent Miscarriage Unsuccessful IVF Cycles Unexplained Infertility Advanced Maternal Age Male Factor Infertility Inherited Genetic Disorders
20
Preimplantation Genetic Diagnosis (PGD)
Embryo Culture Days 1-3 Day 3 Embryos (8-Cell) Blastomere Biopsy Day 3 Day 5-6 Blastocyst Culture, Embryo Transfer and Possible Freeze
21
Assisted Hatching Application Abnormally thick zona pellucida
Frozen/thawed embryos/oocytes Prior failed IVF >37 yrs of age Elevated FSH
22
Fertility Preservation
23
Sperm Freezing Frozen Indefinitely Simple to Freeze
No documented risks from using frozen sperm
24
Egg Freezing -Considered Experimental
-Option for the preservation of fertility in women with malignant diseases -Not ideal for women wishing to delay childbirth
25
Embryo Freezing -Preserve additional embryos for future cycles
-Embryos frozen indefinitely
26
Fresh Embryos From Non-Donor Oocytes
2007 SART National Summary: Age Fresh Embryos From Non-Donor Oocytes <35 35-37 38-40 41-42 Number of cycles 38,372 21,707 19,099 8,865 Percentage of cycles resulting in pregnancies 45.8 37.2 28.2 18.5 Percentage of cycles resulting in live births 39.9 30.5 21.0 11.7 ~5-10% Lower with Frozen Embryos
27
Semen Analysis Identification
Labeling Chain of Custody Isolation Verification Name: John Doe DOB: March, 23, 2010 MR#:
28
IVF/ICSI Identification
Labeling Chain of Custody Isolation Verification
29
Doctors That Are Happy To See You
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.